Fundraising Fox

Lung Therapeutics

Austin, US · Founded 2012 · Texas corporation · 2 known investors

Biotech

Founders & leadership

JB
James Brian WindsorPresident and CEO
SI
Steven IdellNamed on SEC filing

Board

AFAaron Fletcher
Aaron FletcherinBoard directorManaging Partner and Co-Founder at Bios Partners
JW
Joseph WoelkersBoard director
RM
Robert MillsBoard director

Investors · 2

UT Horizon FundAustin
Bios PartnersreportedFort Worthvia Aaron G.L. Fletcher · board

Reported raises · per SEC filings

Form D private placements

$87.5M disclosed across 4 of 5 rounds · 2014–2022

▶$10.1MraisedApr 2022 · 213 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles GarnerExecutive Officer
  • Aaron G.L. FletcherDirector
  • William C. FaireyDirector
  • Brian WindsorExecutive Officer, Director
Offering amount
$15M
Amount sold
$10.1M
Minimum investment
$15K
Finders' fees
$855.5K
Placement agents
Newbridge Securities Corporation
First sale
Mar 2022
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.7MraisedOct 2019 · 42 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven IdellDirector
  • Aaron FletcherDirector
  • R. A. SessionDirector
  • James Brian WindsorExecutive Officer, Director
  • Robert MillsDirector
Offering amount
$38.7M
Amount sold
$38.7M
First sale
May 2019
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$36.2MraisedMay 2019 · 38 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven IdellDirector
  • Aaron FletcherDirector
  • Robert MillsDirector
  • James Brian WindsorExecutive Officer, Director
  • R. A. SessionDirector
Amount sold
$36.2M
First sale
May 2019
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJun 2018 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James Brian WindsorExecutive Officer, Director
  • Steven IdellDirector
  • Aaron FletcherDirector
  • Robert MillsDirector
  • Jim MervisDirector
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedSep 2015 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Aaron FletcherDirector
  • Joseph WoelkersDirector
  • Steven IdellDirector
  • Robert MillsDirector
  • James Brian WindsorExecutive Officer, Director
Offering amount
$2.6M
Amount sold
$2.6M
First sale
Sep 2014
Incorporated
Corporation, Texas, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Lung Therapeutics's investors?
Lung Therapeutics's investors include UT Horizon Fund, Bios Partners.
How much funding has Lung Therapeutics raised?
Lung Therapeutics has disclosed $87.5M raised across 4 of its 5 known rounds.
Where is Lung Therapeutics headquartered?
Lung Therapeutics is headquartered in Austin, US.